Sponsored By

Wireless Implantable Heart Monitor Offers Reassurance

Today's Star Tribune of Minneapolis has a feature on Transoma Medical Inc.'s Sleuth, a wireless implantable device that monitors the electrical activity of the heart and, via a handheld device carried by the patient, transmits the data to caregivers. The firm received FDA approval for Sleuth in October and the article follows one of the first 50 patients to receive it.

March 10, 2008

1 Min Read
Wireless Implantable Heart Monitor Offers Reassurance

The technology could make for faster diagnosis, more efficient treatment management, and fewer visits to the hospital -- which would save money.Interestingly, Transoma started out as a pharmaceutical research firm and developed what became the Sleuth technology to monitor the effects of drugs on animals. It didn't think of the technology as a device that could be used in humans until other firms started making wireless implantable devices. It plans to aim the product at those with chronic conditions such as syncope (unexplained fainting.)

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like